Mediracer®
Related Studies
Mediracer® NCS is toolkit for diagnosing and evaluating carpal tunnel syndrome, diabetic peripheral neuropathy and chemotherapy-induced peripheral neuropathy.
Studies
Below you can find multiple CTS, DPN, CIPN and Mediracer NCS related studies.
Carpal Tunnel Syndrome:
Improving the Diagnosis of Carpal Tunnel Syndrome
Prof Michael Sedgwick, MD FRCP
Nerve conduction studies and EMG in carpal tunnel syndrome: Do they add value?
MasahiroSonoo, Daniel L.Menkes, Jeremy D.P.Bland, DavidBurke. Clinical Neurophysiology Practice Volume 3, 2018, Pages 78-88
A Handheld Nerve Conduction Measuring Device In Carpal Tunnel Syndrome
U.Tolonen, M.Kallio, J.Ryhänen, T.Raatikainen, V.Honkala, V.Lesonen and The Study Group. Acta Neurol Scand DOI: 10.111/j.1600-0404.2007.00799.x
Carpal Tunnel Syndrome Diagnosis: Validation of a Clinic-Based Nerve Conduction Measurement Device
T.Green, M.Kallio, M.Clarke, P.Pathak, V.Lesonen, U.Tolonen. J. Biomedical Science and Engineering, 2011, 4, 280-286
Ring Finger Testing in Carpal Tunnel Syndrome: A Comparative Study of Diagnostic Utility.
Uncini A, Lange DJ, Solomon M, Soliven B, Meer J, Lovelace RE. 1989.
Columbia Presbyterian Medical Center, Department of Neurology
Muscle Nerve, 12: 735–741. doi: 10.1002/mus.880120906
ELECTRODIAGNOSTIC EVALUATION OF CARPAL TUNNEL SYNDROME
Robert A. Werner, MD, MS and Michael Andary, MD, MS
Muscle Nerve 44: 597–607, 2011, AANEM MONOGRAPH
The Relationship of Pre- and Post-operative Median and Ulnar Nerve Conduction Measures to a Self-administered Questionnaire in Carpal Tunnel Syndrome
T.P.Green, E.U.Tolonen, M.R.A.Clarke, P.Pathak, M.L.Newey, C.J.Kershaw, M.A.Kallio
Neurophysiologie Clinique/Clinical Neurophysiology (2012), doi:10.1016/j.neucli.2012.02.133
NCS/EMG examination for common disorders
The British Society for Clinical Neuropsychology.
Diabetic Peripheral Neuropathy
A Clinical Approach to diabetic peripheral neuropathy
Signs and Symptoms vs Nerve Conduction Studies to Diagnose Diabetic Sensorimotor Polyneuropathy
AANEM Policy Statement on Electrodiagnosis for Distal Symmetric Polyneuropathy
“Recently, the number of diabetic patients has increased very rapidly and is accompanied by an increasing development of diabetic neuropathies (DNs). The incidence and prevalence of DNs associated with duration of diabetes affects up to 50% of diabetic patients after 25 years of disease.”
AANEM Policy Statement on Electrodiagnosis for Distal Symmetric Polyneuropathy
“AANEM Policy Statement on Electrodiagnosis for Distal Symmetric Polyneuropathy Introduction Distal symmetric polyneuropathy (DSP) is one of the most common problems leading to referral”
“Peripheral neuropathy is a commonly encountered disorder in both the primary care and podiatric clinical settings. Peripheral neuropathy affects the nerves, which impairs sensation, movement, gland or organ function, and other aspects of well-being, including mental health.”
“The prevalence of diabetes is rapidly rising all over the globe and India is becoming the world capital for diabetic patients. Persistent hyperglycemia leads to micro vascular complications like diabetic peripheral neuropathy (DPN) which contributes to significant morbidity in the society.”
Point-of-care devices for detecting diabetic polyneuropathy
01 July 2016 – Publisher: NIHR Community Healthcare MIC
Electrodiagnostic Services: Pay for Quality – aanem.org
The British Society for Clinical Neuropsychology
NCS/EMG examination for common disorders
Chemotherapy-Induced Peripheral Neuropathy
Co-Morbidity Consult: Chemotherapy-Induced Peripheral Neuropathy
Neurophysiological Study of Peripheral Neuropathy after High-Dose Paclitaxel
Mediracer® NCS
Quality of our solutions
Are proven by ISO 13485 standard (VTT-C-12332-60-18) and CE mark (VTT-C-11550-01-1102-578-16).
Mediracer has entered the US market after the FDA 510(k) review for premarket notification for the Mediracer® NCS system was successfully completed (SE).
Phone
+358 45 899 2626
info (at) mediracer.com
Location
kasarmintie 13 D
Oulu, 90130
Finland